India to United States: Paclitaxel Export Trade Route

The India to United States Paclitaxel corridor is one of India's established pharmaceutical export routes, with 196 shipments documented worth a combined $8.4M USD. The route is dominated by MSN LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 67% of all export value, reflecting the consolidated nature of India's paclitaxel manufacturing sector.

Across 16 active suppliers, the average shipment value stands at $42.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with paclitaxel's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 30.6%, placing it at rank #4 among India's top paclitaxel export destinations globally.

On the import side, key buyers of Indian paclitaxel in United States include TO THE ORDER OF, J. KNIPPER & COMPANY, AMERICAN HEALTH PACKAGING and 28 others. TO THE ORDER OF is the single largest importer with 32 shipments valued at $2.1M USD.

India's paclitaxel exports to United States are driven primarily by a handful of large-scale manufacturers. MSN LABORATORIES PRIVATE LIMITED with 90 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 16 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, GLAND PHARMA LIMITED — together account for 98% of total trade value on this route. The average shipment value of $42.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as paclitaxel inj 300mg/50ml 1's and paclitaxel inj usp 300mg 50ml ap us, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF is the largest importer with 32 shipments worth $2.1M USD — representing 25% of all paclitaxel imports from India on this route. A total of 31 buyers are active on this corridor.